{
  "id": 5609303,
  "title": "Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases",
  "url": "https://urgent.news/2026/09/04/medicines-discovery-catapult-backs-two-u-k-biotech-companies-tackling",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-04T17:28:32.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/drug-discovery/medicines-discovery-catapult-backs-two-u-k-biotech-companies-tackling-chronic-diseases/"
  },
  "original_language": "en",
  "account": "Medicines Discovery Catapult (MDC) has provided £500,000 in funding to two U.K. biotechnology firms focused on innovative therapies for chronic diseases. Flip Therapeutics and Nascent Therapeutics will receive financial backing from Innovate UK as part of a scheme designed to support high-potential companies in receiving MDC investment and access to translational drug discovery expertise. Flip Therapeutics aims to develop a method for reprogramming T cells directly in the body to generate long-lasting, controlled immune function in patients with autoimmune and inflammatory diseases such as psoriasis and alopecia areata. Nascent Therapeutics, a spinout from the University of East Anglia, is using mitochondrial biology to target neurodegenerative diseases, cancer, and age-related conditions like COPD and osteoporosis. With the support of MDC, both companies will focus on validating their approaches and developing scalable therapeutic platforms to address the unmet medical needs of patients suffering from these conditions.",
  "summary": "Medicines Discovery Catapult provided its investment and expert support to help two biotech companies accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases. The post Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}